Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Invested Capital (2016 - 2025)

Historic Invested Capital for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $353.0 million.

  • Phibro Animal Health's Invested Capital rose 3419.36% to $353.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $353.0 million, marking a year-over-year increase of 3419.36%. This contributed to the annual value of $301.9 million for FY2025, which is 540.99% up from last year.
  • Latest data reveals that Phibro Animal Health reported Invested Capital of $353.0 million as of Q4 2025, which was up 3419.36% from $330.1 million recorded in Q3 2025.
  • Phibro Animal Health's Invested Capital's 5-year high stood at $353.0 million during Q4 2025, with a 5-year trough of $239.4 million in Q1 2021.
  • Over the past 5 years, Phibro Animal Health's median Invested Capital value was $283.0 million (recorded in 2022), while the average stood at $283.7 million.
  • In the last 5 years, Phibro Animal Health's Invested Capital tumbled by 1138.5% in 2024 and then soared by 3419.36% in 2025.
  • Over the past 5 years, Phibro Animal Health's Invested Capital (Quarter) stood at $252.4 million in 2021, then increased by 12.43% to $283.8 million in 2022, then rose by 4.6% to $296.8 million in 2023, then dropped by 11.38% to $263.1 million in 2024, then soared by 34.19% to $353.0 million in 2025.
  • Its last three reported values are $353.0 million in Q4 2025, $330.1 million for Q3 2025, and $301.9 million during Q2 2025.